Results 41 to 50 of about 13,720 (189)

The Heart Team during the Pandemic: A Case Report of Bio-Prosthesis Degeneration Treated with Valve in Valve Implantation

Journal of Cardiovascular Echography
The pandemic changed the type of patients. The concept of “patient at the center” became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The “Heart Team” model is on increasing affirmation.
Manes, Maria Teresa, Ritacco, Anna Rita, Cassano, Susanna, Ferrò, Maria Teresa, Manduca, Bruno, Spaccarotella, Carmen, Musacchio, Domenico   +6 more
openaire   +2 more sources

Comparative Outcomes of Transcatheter Versus Surgical Pulmonary Valve Replacement in Adults With Congenital Heart Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Pulmonary valve replacement is frequently required in adults with congenital heart disease (CHD). Comparative real‐world outcomes between percutaneous transcatheter pulmonary valve implantation (TPVR) and surgical pulmonary valve replacement (SPVR) remain incompletely characterized. We evaluated outcomes and resource utilization for
Adam Bolad, Mohamed Elganainy, Fawaz Alenezi, Issam Motairek, Islam Bolad   +4 more
wiley   +1 more source

Various clinical factors’ influence on long-term results of valve prosthetic surgery in heart valve disease

Кардиоваскулярная терапия и профилактика, 2005
Aim. To assess factors influencing the long-term results of valve prosthetic surgery in heart valve disease. Material and methods. In total, 310 patients with heart valve surgery in anamnesis were examined: 168 females (54%), 142 males (46%); mean age 54.
L. I. Murzabekova, V. A. Orlov
doaj  

Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report

Frontiers in Cardiovascular Medicine, 2022
BackgroundCoronary occlusion is an uncommon but fatal complication of transcatheter aortic valve replacement (TAVR) with a poor prognosis.Case PresentationA patient with symptomatic severe bicuspid aortic valve stenosis was admitted to a high-volume ...
Hanyi Dai, Hanyi Dai, Dao Zhou, Dao Zhou, Jiaqi Fan, Lihan Wang, Abuduwufuer Yidilisi, Abuduwufuer Yidilisi, Gangjie Zhu, Gangjie Zhu, Jubo Jiang, Huajun Li, Xianbao Liu, Xianbao Liu, Jian’an Wang, Jian’an Wang   +15 more
doaj   +1 more source

Consecutive Emergency Carotid Artery Stenting and Transcatheter Aortic Valve Replacement in a Patient With Cardiogenic Shock: A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe aortic stenosis (AS) carries a poor prognosis when symptomatic, particularly in cardiogenic shock (CS). Emergency transcatheter aortic valve replacement (TAVR) is rarely performed but may represent a rescue therapy. Coexistent carotid artery stenosis (CAS) further increases procedural risk.
Max Groche, Claudio Silwanis, Clemens Steinwender, Thomas Lambert   +3 more
wiley   +1 more source

Late migration of transcatheter aortic valve replacement prosthesis [PDF]

Българска кардиология
Transcatheter aortic valve replacement (TAVR) is an established therapy for severe aortic stenosis, particularly in high-risk surgical candidates.
G. Goranov, E. Georgieva
doaj   +3 more sources

Cinefluoroscopy for assessment of mechanical heart valves with suspected dysfunction

Frontiers in Cardiovascular Medicine, 2022
BackgroundMechanical heart valves (MHVs) are preferred prosthesis types in many, especially younger patients who need surgical valve replacement.
Anselm A. Derda, Marvin M. Marquardt, Andreas Martens, Elion Mirena, Jens Vogel-Claussen, Tibor Kempf, Axel Haverich, Johann Bauersachs, L. Christian Napp   +8 more
doaj   +1 more source

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis

Journal of the American College of Cardiology, 2004
This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent.
Cribier, Alain, Eltchaninoff, Hélène, Tron, Christophe, Bauer, Fabrice, Agatiello, Carla, Sebagh, Laurent, Bash, Assaf, Nusimovici, Danielle, Litzler, P.Y, Bessou, Jean-Paul, Leon, Martin B   +10 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß, Philipp Mourikis, Fabian Nienhaus, Jafer Haschemi, Alexander Hoss, Tobias Zeus, Hanna Kowalski, Maximilian Spieker, Christian Jung, Patrick Horn, Hug Aubin, Artur Lichtenberg, Richard Truse, Malte Kelm, Amin Polzin   +14 more
wiley   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

ChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source